A true closed system.
Discover HALO®, your complete solution for hazardous drug preparation and administration.
Each year, millions of healthcare workers are exposed to chemotherapy and other hazardous drugs while preparing and administering drug therapies to patients.1 The HALO system from Fresenius Kabi is an airtight and leak-proof closed system drug-transfer device (CSTD) that mechanically prohibits the transfer of environmental contaminants into the system and the escape of drug or vapor concentrations outside the system – thereby minimizing individual and environmental exposure to drug vapor, aerosols and spills.
The HALO system also prevents microbial ingress for up to 168 hours.2*
Make the HALO system your standard of care for enhanced protection of patients and caregivers.
The HALO system offers a smarter CSTD solution.
Airtight, secure connections provide a proven physical barrier that prevents the transfer of contaminants into the system and the escape of drug or vapor concentrations outside the system to protect against exposure.
- ONB product code3
- Strong and secure vial adaptor connection up to 14 perforations4
- Up to 7 days of microbial ingress prevention
- Membrane to membrane connection
Easy to Use
Designed for simplicity and comfort, with fewer pieces, fewer steps and single-motion connections.
- Needle-safe design reduces risk of accidental needle stick3
- Minimal vial touch points mean less risk of contamination
- Simple, secure connections
- Easy-to-swab raised seals4
- Snap-on vial adaptor mechanism requiring minimal applied force
- Easy to grip, ergonomically designed for hand comfort5
- Compatible with standard IV bags, luer connections and infusion sets3,6
- Available in three vial sizes and compatible with most vial types, syringes, pumps, IV bags and infusion lines
- Designed to maximize medication extraction from vial
- Fewest number of components, making it easy to use and stock
HALO® is a registered trademark of Corvida Medical, Inc.Sources:
- NIOSH Alert: Preventing occupational exposure to antineoplastic and other hazardous drugs in health care settings. http://www.cdc.gov/niosh/docs/2004-165/ Publication No. 2004-165. Washington DC: NIOSH; 2004.
- Health and Human Services, Federal Drug Administration, 510(k) Clearance Letter, July 24, 2015.
- Bartel SB, Tyler TG, Power LA, Multicenter evaluation of a new closed system drug-transfer device in reducing surface contamination by antineoplastic hazardous drugs, Am J Health-Syst Pharm. 2018; 75:199-211.
- Internal study, data on file.
- Ergonomics: The Study of Work U.S. Department of Labor Occupational Safety and Health Administration OSHA 3125 2000 (Revised).
- ISO 80369-7: 2021. Small-bore connectors for liquids and gases in healthcare applications — Part 7: Connectors for intravascular or hypodermic applications.